Dopamine D3 receptor agents as potential new medications for drug addiction

No abstract is available for this paper.

• Publication year

  2000

• Venue

  European psychiatry

• Publication date

  2000-03-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/S0924-9338(00)00219-4PMID 10881212
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• D1 and D2 receptor antagonists differently affect cocaine-induced locomotor hyperactivity in the mouse

  2005cited by this paper
• Repeated exposures intensify rather than diminish the rewarding effects of amphetamine, morphine, and cocaine

  2004cited by this paper
• Reinstatement of cocaine-reinforced responding in the rat

  2004cited by this paper
• Selective inhibition of cocaine-seeking behaviour by a partial dopamine D3 receptor agonist

  1999cited by this paper
• Acquisition, maintenance and reinstatement of intravenous cocaine self-administration under a second-order schedule of reinforcement in rats: effects of conditioned cues and continuous access to cocaine

  1998cited by this paper
• Homozygosity at the dopamine D3 receptor gene is associated with opiate dependence

  1998cited by this paper
• Dopamine D3 receptor gene variants and substance abuse in schizophrenia

  1998cited by this paper
• Coexpression of dopamine D1 and D3 receptors in islands of Calleja and shell of nucleus accumbens of the rat: opposite and synergistic functional interactions

  1998cited by this paper
• Relapse to drug-seeking: neural and molecular mechanisms.

  1998cited by this paper
• Two Intracellular Signaling Pathways for the Dopamine D3 Receptor: Opposite and Synergistic Interactions with Cyclic AMP

  1997cited by this paper
• Lesions of the basolateral amygdala abolish the ability of drug associated cues to reinstate responding during withdrawal from self-administered cocaine.

  1997cited by this paper
• Induction of dopamine D3 receptor expression as a mechanism of behavioral sensitization to levodopa.

  1997cited by this paper
• D3 receptor test in vitro predicts decreased cocaine self‐administration in rats

  1997cited by this paper
• Up-regulation of D3 dopamine receptor mRNA in the nucleus accumbens of human cocaine fatalities.

  1997cited by this paper
• The biological, social and clinical bases of drug addiction: commentary and debate

  1996cited by this paper
• gp130, a Shared Signal Transducing Receptor Component for Hematopoietic and Neuropoietic Cytokines

  1996cited by this paper
• Conditioned cued recovery of responding following prolonged withdrawal from self-administered cocaine in rats: an animal model of relapse.

  1996cited by this paper
• Self-administration of D1 receptor agonists by squirrel monkeys

  1996cited by this paper
• Dopamine D3 receptor agonists partially reproduce the discriminative stimulus effects of cocaine in squirrel monkeys.

  1996cited by this paper
• Effects of the putative dopamine D3 receptor agonist 7-OH-DPAT in rhesus monkeys trained to discriminate cocaine from saline

  1996cited by this paper
• Adaptive Increase in D3 Dopamine Receptors in the Brain Reward Circuits of Human Cocaine Fatalities

  1996cited by this paper
• Myths about the treatment of addiction.

  1996cited by this paper
• A paradoxical regulation of the dopamine D3 receptor expression suggests the involvement of an anterograde factor from dopamine neurons.

  1995cited by this paper
• Pretreatment with the dopamine agonist 7‐OH‐DPAT shifts the cocaine self‐administration dose‐effect function to the left under different schedules in the rat

  1995cited by this paper
• Neuronal adaptation to amphetamine and dopamine: molecular mechanisms of prodynorphin gene regulation in rat striatum.

  1995cited by this paper
• Phenotypical characterization of neurons expressing the dopamine D3 receptor in the rat brain.

  1995cited by this paper
• Differential blockade of chronic versus acute effects of intravenous cocaine by dopamine receptor antagonists.

  1994cited by this paper
• Dopamine receptor agonists, partial agonists and psychostimulant addiction.

  1994cited by this paper
• Effects of dopamine D-1 and D-2 antagonists on cocaine self-administration under different schedules of reinforcement in the rat.

  1994cited by this paper
• The nucleus accumbens as a complex of functionally distinct neuronal ensembles: an integration of behavioural, electrophysiological and anatomical data.

  1994cited by this paper
• D1 dopamine receptors in the nucleus accumbens modulate cocaine self-administration in the rat.

  1993cited by this paper
• Modulation of cocaine self-administration in the rat through D-3 dopamine receptors.

  1993cited by this paper
• On the significance of subterritories in the "accumbens" part of the rat ventral striatum.

  1992cited by this paper
• Dopamine, addiction and reward

  1992cited by this paper
• A learning model of addiction.

  1992cited by this paper
• Molecular mechanisms of drug addiction [published erratum appears in J Neurosci 1992 Aug;12(8):following table of contents]

  1992cited by this paper
• Identification, characterization, and localization of the dopamine D3 receptor in rat brain using 7-[3H]hydroxy-N,N-di-n-propyl-2-aminotetralin.

  1992cited by this paper
• Cocaine addiction: psychology and neurophysiology.

  1991cited by this paper
• Discriminative stimulus effects of cocaine in squirrel monkeys: involvement of dopamine receptor subtypes.

  1991cited by this paper
• Brain-stimulation reward: a review.

  1991cited by this paper
• Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity.

  1991cited by this paper
• Localization of dopamine D3 receptor mRNA in the rat brain using in situ hybridization histochemistry: comparison with dopamine D2 receptor mRNA.

  1991cited by this paper
• Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics

  1990cited by this paper
• Preexposure sensitizes rats to the rewarding effects of cocaine.

  1990cited by this paper
• Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats.

  1988cited by this paper
• The Rat nervous system

  1985cited by this paper
• Effects of repeated methamphetamine administration on methamphetamine self-administration in rhesus monkeys.

  1984cited by this paper
• Conditioned and unconditioned drug effects in relapse to opiate and stimulant drug self-administration

  1983cited by this paper
• Dynamics of drug dependence. Implications of a conditioning theory for research and treatment.

  1973cited by this paper

• Emerging Therapeutics in the Treatment of Substance Use Disorders: A Focus on GLP-1 Receptor Agonists, D3R Antagonists, and CRF Antagonists.

  2025cites this paper
• Biased Signaling Agonists of Dopamine D3 Receptor Differentially Regulate the Effects of Cocaine On Dopamine Transporter Function

  2025cites this paper
• G-protein Biased Signaling Agonists of Dopamine D3 Receptor Promote Distinct Activation Patterns of ERK1/2.

  2022cites this paper
• The Role of Dopamine D3 Receptors in Tobacco Use Disorder: A Synthesis of the Preclinical and Clinical Literature.

  2022cites this paper
• New class of benzothiophene morpholine analogues with high selectivity and affinity were designed and evaluated for anti‐drug addiction

  2022cites this paper
• Principles and approaches in Hans Eysenck's personality theory: Their renaissance and development in current neurochemical research on individual differences

  2021cites this paper
• Design, synthesis and preliminary bioactivity evaluation of bitopic benzopyranomorpholine analogues as selective dopamine D3 receptor ligands as anti-drug addiction therapeutic agents.

  2021cites this paper
• Abnormalities of Neurotransmission in Drug Addiction

  2020cites this paper
• Effects of chronic nicotine exposure on Δ9-tetrahydrocannabinol-induced locomotor activity and neural activation in male and female adolescent and adult rats.

  2020cites this paper
• The Long-Acting D3 Partial Agonist MC-25-41 Attenuates Motivation for Cocaine in Sprague-Dawley Rats

  2020cites this paper
• Chronic nicotine exposure attenuates the effects of Δ9‐tetrahydrocannabinol on anxiety‐related behavior and social interaction in adult male and female rats

  2019cites this paper
• Fatigue and stress reactivity are differently related to cigarette craving and hormone responses to neurotransmitter related drugs in nicotine deprived smokers

  2017cites this paper
• Dopamine D3 Receptor Antagonist (GSK598809) Potentiates the Hypertensive Effects of Cocaine in Conscious, Freely-Moving Dogs

  2015cites this paper
• Design, synthesis, and biological evaluation of sigma receptors (σRS) ligands as potential pharmacotherapy for cancer and drug addiction

  2015cites this paper
• The dopamine D3 receptor: From preclinical studies to the treatment of psychiatric disorders.

  2015cites this paper
• Characterization of preclinical in vitro and in vivo ADME properties and prediction of human PK using a physiologically based pharmacokinetic model for YQA‐14, a new dopamine D3 receptor antagonist candidate for treatment of drug addiction

  2014cites this paper
• Recent methods for measuring dopamine D3 receptor occupancy in vivo: importance for drug development

  2014cites this paper
• Dopamine D3 receptor ligands for drug addiction treatment: update on recent findings.

  2014cites this paper
• The dopamine D3 receptor antagonist YQA14 that inhibits the expression and drug-primed reactivation of morphine-induced conditioned place preference in rats.

  2013cites this paper
• The dopamine D(3) receptor antagonist YQA14 that inhibits the expression and drug-prime reactivation of morphine-induced conditioned place preference in rats.

  2013cites this paper
• Effects of Chronic Buspirone Treatment on Cocaine Self-Administration

  2013cites this paper
• Reinforcing properties of Pramipexole in normal and parkinsonian rats.

  2013cites this paper
• Modification of cocaine self-administration by buspirone (buspar®): potential involvement of D3 and D4 dopamine receptors.

  2013cites this paper
• Effects of Chronic Buspirone Treatment on Nicotine and Concurrent Nicotine+Cocaine Self-Administration

  2013cites this paper
• The D2/3 dopamine receptor in pathological gambling: a positron emission tomography study with [11C]-(+)-propyl-hexahydro-naphtho-oxazin and [11C]raclopride.

  2013cites this paper
• Dopamine D3 receptor antagonists in pathologic gambling.

  2013cites this paper
• Dopamine D(3) receptor as a new pharmacological target for the treatment of depression.

  2013cites this paper
• YQA14: a novel dopamine D3 receptor antagonist that inhibits cocaine self‐administration in rats and mice, but not in D3 receptor‐knockout mice

  2012cites this paper
• Dopamine D3 Receptor Antagonists in Pathologic Gambling.

  2012cites this paper
• Neurobiology of Disease

  2012cites this paper
• The Role of the Dopamine D, Receptors in Cue-induced Reinstatement of Nicotine-seeking Behaviour

  2011cites this paper
• Current perspectives on selective dopamine D3 receptor antagonists as pharmacotherapeutics for addictions and related disorders

  2010cites this paper
• The selective dopamine D3 receptor antagonist SB 277011-A, but not the partial agonist BP 897, blocks cue-induced reinstatement of nicotine-seeking.

  2010cites this paper
• Important role of 3-methoxytyramine in the inhibition of cocaine sensitization by 1-methyl-1,2,3,4-tetrahydroisoquinoline: an in vivo microdialysis study

  2010cites this paper
• Dopamine Receptor Subtypes in Reward and Relapse

  2010cites this paper
• Both Stereoselective (R)- and (S)-1-Methyl-1,2,3,4-tetrahydroisoquinoline Enantiomers Protect Striatal Terminals Against Rotenone-Induced Suppression of Dopamine Release

  2010cites this paper
• Novel pharmacological approaches to drug abuse treatment.

  2010cites this paper
• Evidence for the role of the dopamine D3 receptor in mediating methamphetamine addiction

  2009cites this paper
• Effects of nicotine in experimental animals and humans: an update on addictive properties.

  2009cites this paper
• 1-Methyl-1,2,3,4-tetrahydroisoquinoline Antagonizes a Rise in Brain Dopamine Metabolism, Glutamate Release in Frontal Cortex and Locomotor Hyperactivity Produced by MK-801 but not the Disruptions of Prepulse Inhibition, and Impairment of Working Memory in Rat

  2009cites this paper
• Topiramate does not alter nicotine or cocaine discrimination in rats

  2008cites this paper
• [Future medications for tobacco and cannabis dependence].

  2008cites this paper
• Selective antagonism at dopamine D3 receptors as a target for drug addiction pharmacotherapy: a review of preclinical evidence.

  2008cites this paper
• Nicotine place preference in a biased conditioned place preference design.

  2008cites this paper
• Enhanced apomorphine sensitivity and increased binding of dopamine D2 receptors in nucleus accumbens in prepubertal rats after neonatal blockade of the dopamine D3 receptors by (+)‐S14297

  2008cites this paper
• Quels futurs traitements pour la dépendance au tabac et au cannabis

  2008cites this paper
• The effect of an endogenous compound 1-methyl-1,2,3,4,-tetrahydroisoquinoline on morphine-induced analgesia, dependence and neurochemical changes in dopamine metabolism in rat brain structures.

  2007cites this paper
• Chapitre 5 – Cocaïne

  2007cites this paper
• Treatment of problem cocaine use : a review of the literature

  2007cites this paper
• Regulation of Dopamine Transporter Function and Cell Surface Expression by D3 Dopamine Receptors*

  2007cites this paper
• Neurochemical Adaptations and Cocaine Dependence

  2007cites this paper
• Effect of the selective dopamine D3 receptor antagonist SB-277011-A on regional c-Fos-like expression in rat forebrain.

  2007cites this paper
• Maternal deprivation and handling modify the effect of the dopamine D3 receptor agonist, BP 897 on morphine-conditioned place preference in rats

  2007cites this paper
• An endogenous neuroprotectant substance, 1-methyl-1,2,3,4-tetrahydroisoquinoline (1MeTIQ), prevents the behavioral and neurochemical effects of cocaine reinstatement in drug-dependent rats

  2007cites this paper
• Dual alteration of limbic dopamine D1 receptor‐mediated signalling and the Akt/GSK3 pathway in dopamine D3 receptor mutants during the development of methamphetamine sensitization

  2007cites this paper
• The Novel Dopamine D3 Receptor Antagonist NGB 2904 Inhibits Cocaine's Rewarding Effects and Cocaine-Induced Reinstatement of Drug-Seeking Behavior in Rats

  2006cites this paper
• Other Nonapproved Agents for Smoking Cessation

  2006cites this paper
• The Genetics of Gambling and Behavioral Addictions

  2006cites this paper
• Dopamine D3 as well as D2 receptor ligands attenuate the cue-induced cocaine-seeking in a relapse model in rats.

  2006cites this paper
• BP 897, a selective dopamine D3 receptor ligand with therapeutic potential for the treatment of cocaine-addiction.

  2006cites this paper
• Nicotine as a typical drug of abuse in experimental animals and humans

  2006cites this paper
• Dopamine challenge tests as an indicator of psychological traits

  2006cites this paper
• Targeting the Dopamine D 3 Receptor for Treatment of Nicotine Dependence

  2006cites this paper
• Dopamine D3 receptor antagonists improve the learning performance in memory-impaired rats

  2005cites this paper
• The dopamine D(3) receptor-preferring partial agonist BP 897 dose-dependently attenuates the expression of amphetamine-conditioned place preference in rats.

  2005cites this paper
• Association between dopamine receptor D3 gene BalI polymorphism and cognitive impulsiveness in alcohol-dependent men

  2005cites this paper
• The dopamine D3 receptor and drug dependence: effects on reward or beyond?

  2005cites this paper
• Control of the reinforcing effects of nicotine by associated environmental stimuli in animals and humans.

  2005cites this paper
• Nicotine induces conditioned place preferences over a large range of doses in rats

  2005cites this paper
• Ethanol does not affect discriminative-stimulus effects of nicotine in rats.

  2005cites this paper
• Dopamine D3 Receptor Ligands Block Nicotine-Induced Conditioned Place Preferences through a Mechanism that does not Involve Discriminative-Stimulus or Antidepressant-Like Effects

  2005cites this paper
• Dopamine D3 receptor partial agonists and antagonists as potential drug abuse therapeutic agents.

  2005cites this paper
• Cannabinoid CB1 Receptor Antagonists as Promising New Medications for Drug Dependence

  2005cites this paper
• The dopamine D3 receptor-preferring partial agonist BP 897 dose-dependently attenuates the expression of amphetamine-conditioned place preference in rats

  2005cites this paper
• Neuroadaptations to hyperdopaminergia in dopamine D3 receptor-deficient mice.

  2005cites this paper
• The role of central dopamine D3 receptors in drug addiction: a review of pharmacological evidence.

  2005cites this paper
• Lack of functional D2 receptors prevents the effects of the D3-preferring agonist (+)-PD 128907 on dialysate dopamine levels.

  2005cites this paper
• The role of BDNF in epilepsy and other diseases of the mature nervous system.

  2004cites this paper
• Blockade of mesolimbic dopamine D3 receptors inhibits stress-induced reinstatement of cocaine-seeking in rats

  2004cites this paper
• Role of DRD3 in morphine-induced conditioned place preference using drd3-knockout mice

  2004cites this paper
• Recent Advances in Epilepsy Research

  2004cites this paper
• Intra-BLA or intra-NAc infusions of the dopamine D3 receptor partial agonist, BP 897, block intra-NAc amphetamine conditioned activity.

  2004cites this paper
• Cannabinoid Cb 1 Receptor Antagonists as Promising New Medications for Drug Dependence Cb 1 Receptors Modulate the Brain Reward Pathway

  2004cites this paper
• The ser9gly SNP in the dopamine D3 receptor causes a shift from cAMP related to PGE2 related signal transduction mechanisms in transfected CHO cells

  2004cites this paper
• N-(4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl, butenyl and butynyl)arylcarboxamides as novel dopamine D(3) receptor antagonists.

  2003cites this paper
• Disruption of nicotine conditioning by dopamine D3 receptor ligands

  2003cites this paper
• Targeting the dopamine D3 receptor cannot influence continuous reinforcement cocaine self-administration in rats.

  2003cites this paper
• Dopamine D3 receptor ligands show place conditioning effect but do not influence cocaine-induced place preference

  2003cites this paper
• N-(omega-(4-(2-methoxyphenyl)piperazin-1-yl)alkyl)carboxamides as dopamine D2 and D3 receptor ligands.

  2003cites this paper
• Increased dopamine D3 receptor expression accompanying behavioral sensitization to nicotine in rats

  2003cites this paper
• Non-nicotinic neuropharmacological strategies for nicotine dependence: beyond bupropion.

  2003cites this paper
• Sigma1 (σ1) receptor antagonists represent a new strategy against cocaine addiction and toxicity

  2002cites this paper
• The potential of dopamine agonists in drug addiction

  2002cites this paper
• Dopamine agonist and antagonist responders as related to types of nicotine craving and facets of extraversion.

  2002cites this paper
• Une approche thérapeutique centrée sur les effets conditionnels des drogues

  2002cites this paper
• Sigma(1) (sigma(1)) receptor antagonists represent a new strategy against cocaine addiction and toxicity.

  2002cites this paper
• Role of dopamine D3 receptors in controlling the expression of cocaine sensitization in rats.

  2002cites this paper
• The role of cortisol suppression on craving for and satisfaction from nicotine in high and low impulsive subjects

  2002cites this paper
• Does combined treatment with novel antidepressants and a dopamine D3 receptor agonist reproduce cocaine discrimination in rats?

  2001cites this paper
• Design and synthesis of [(2,3-dichlorophenyl)piperazin-1-yl]alkylfluorenylcarboxamides as novel ligands selective for the dopamine D3 receptor subtype.

  2001cites this paper